Liyuan Zhong

机构：BGI Group (China), Capital Medical University · ORCID：0009-0006-5511-6432

发表论文 18 篇 · 总被引 237 次 · h-index 7

代表论文

Endothelial glycocalyx as an important factor in composition of blood‐brain barrier (2020 · CNS Neuroscience & Therapeutics · 被引 86)
Long non-coding RNA H19: Physiological functions and involvements in central nervous system disorders (2021 · Neurochemistry International · 被引 44)
Comparative spatial transcriptomics reveals root dryland adaptation mechanism in rice and HMGB1 as a key regulator (2025 · Molecular Plant · 被引 22)
Elevated plasma syndecan-1 as glycocalyx injury marker predicts unfavorable outcomes after rt-PA intravenous thrombolysis in acute ischemic stroke (2022 · Frontiers in Pharmacology · 被引 16)
Fingolimod Alleviates Inflammation after Cerebral Ischemia via HMGB1/TLR4/NF-κB Signaling Pathway (2024 · Journal of Integrative Neuroscience · 被引 13)
LncRNAs: Promising Therapeutic Targets and Biomarkers for Ischemic Stroke (2022 · Translational Stroke Research · 被引 12)